Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

EnQuest signs production sharing contracts in Indonesia

(Sharecast News) - EnQuest announced Tuesday that it has signed production sharing contracts with the Indonesian government and joint venture partners for the Gaea and Gaea II exploration blocks in Papua Barat, marking its entry into Indonesia. Under the agreements, EnQuest said it would hold a 40% operating interest in the blocks, with the Tangguh Joint Venture holding 40% and PT Agra Energi Indonesia the remaining 20%.

The London-listed firm said the blocks, located near the BP-operated Tangguh LNG facility, were estimated by Indonesia's Ministry of Energy and Mineral Resources to hold more than 100 trillion standard cubic feet (Tscf) of unrisked resource potential.

"We are very proud to have been selected as the operating partner on the Gaea and Gaea II PSC blocks," said chief executive Amjad Bseisu.

"This award is a testament to the trust the Indonesian government has placed in EnQuest, and we are committed to working with the Tangguh Joint Venture and PT Agra Energi Indonesia to unlock the full potential of these blocks."

EnQuest said the contracts could add significant upside to its South East Asia portfolio, from which it expected to deliver more than 35,000 barrels of oil equivalent per day by 2030.

Further updates on the projects would be provided alongside its half-year results on 24 September, the board said.

At 1027 BST, shares in EnQuest were up 1.88% at 12.98p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.